English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 52 Help

Selected(0)Clear Items/Page:    Sort:
AI-directed formulation strategy design initiates rational drug development Journal article
Wang, Nannan, Dong, Jie, Ouyang, Defang. AI-directed formulation strategy design initiates rational drug development[J]. Journal of Controlled Release, 2025, 378, 619-636.
Authors:  Wang, Nannan;  Dong, Jie;  Ouyang, Defang
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:10.5/10.6 | Submit date：2025/01/22
Artificial Intelligence  Formulation Strategy Design  Partially Supervised Learning  Poorly Water-soluble Drugs  Positive-unlabeled Learning  Rational Drug Development  
Self-catalyzed nitric oxide nanocomplexes induce ferroptosis for cancer immunotherapy Journal article
Zhu, Lipeng, Leng, Dongliang, Guo, Ziang, Zhao, Yuetao, Leung, Kam Tong, Dai, Yeneng, Li, Junnan, Zhao, Qi. Self-catalyzed nitric oxide nanocomplexes induce ferroptosis for cancer immunotherapy[J]. Journal of Controlled Release, 2025, 377, 524-539.
Authors:  Zhu, Lipeng;  Leng, Dongliang;  Guo, Ziang;  Zhao, Yuetao;  Leung, Kam Tong; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:10.5/10.6 | Submit date：2025/01/22
Checkpoint Blockade Immunotherapy  Fe2++ Overloading  Ferroptosis  Self-catalyzed No naNocomplexes  Sirna  
Minocycline nanoplatform penetrates the BBB and enables the targeted treatment of Parkinson's disease with cognitive impairment Journal article
Cheng, Guowang, Liu, Zhiwen, Yan, Zhao, Wu, Jiaxin, Li, Zilin, Gao, Sijia, Zheng, Chunye, Guo, Shuanshuan, Pan, Yue, Chen, Xiaojia, Lin, Guanghui, Zhou, Jianhua, Chen, Tongkai. Minocycline nanoplatform penetrates the BBB and enables the targeted treatment of Parkinson's disease with cognitive impairment[J]. Journal of Controlled Release, 2025, 377, 591-605.
Authors:  Cheng, Guowang;  Liu, Zhiwen;  Yan, Zhao;  Wu, Jiaxin;  Li, Zilin; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:10.5/10.6 | Submit date：2025/01/22
Blood-brain Barrier  Cognitive Impairment  Nanomedicine  Neuroprotection  Parkinson's Disease  
A ROS-responsive hydrogel that targets inflamed mucosa to relieve ulcerative colitis by reversing intestinal mucosal barrier loss Journal article
Wang, Jianwei, Lv, Xiaojia, Li, Ying, Wu, Haiqiang, Chen, Meiwan, Yu, Hua, Wu, Jianwei, Li, Chenyang, Xiong, Wei. A ROS-responsive hydrogel that targets inflamed mucosa to relieve ulcerative colitis by reversing intestinal mucosal barrier loss[J]. Journal of Controlled Release, 2025, 377, 606-618.
Authors:  Wang, Jianwei;  Lv, Xiaojia;  Li, Ying;  Wu, Haiqiang;  Chen, Meiwan; et al.
Favorite | TC[WOS]:0 TC[Scopus]:1  IF:10.5/10.6 | Submit date：2025/01/22
Hydrogel  Intestinal Barrier  Mucosal Healing  Ros-responsive  Ulcerative Colitis  
Corrigendum to “Bacteria-mimetic nanomedicine for targeted eradication of intracellular MRSA” [Journal of Controlled Release 357 (2023) 371–378, (S0168365923002444), (10.1016/j.jconrel.2023.03.053)] Other
2024-12-01
Authors:  Xie, Beibei;  Zhao, Huichao;  Zhang, Ruixue;  Ding, Yuanfu;  Gao, Cheng; et al.
Favorite | TC[WOS]:0 TC[Scopus]:1 | Submit date：2024/12/05
Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization Journal article
Xiang, Yongguo, Qiu, Zhu, Ding, Yuanfu, Du, Miaomiao, Gao, Ning, Cao, Huijie, Zuo, Hangjia, Cheng, Hong, Gao, Xiang, Zheng, Shijie, Wan, Wenjuan, Huang, Xiaobei, Hu, Ke. Dexamethasone-loaded ROS stimuli-responsive nanogels for topical ocular therapy of corneal neovascularization[J]. Journal of Controlled Release, 2024, 372, 874-884.
Authors:  Xiang, Yongguo;  Qiu, Zhu;  Ding, Yuanfu;  Du, Miaomiao;  Gao, Ning; et al.
Favorite | TC[WOS]:1 TC[Scopus]:2  IF:10.5/10.6 | Submit date：2024/08/05
Nanogel  Host-guest Interaction  Corneal Neovascularization  Dexamethasone  Reactive Oxygen Species  Stimuli-responsive  
Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironment Journal article
Huang Shigaao, YUAN ZHEN, Zhao Qi. Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironment[J]. Journal of Controlled Release, 2024, 362, 524-535.
Authors:  Huang Shigaao;  YUAN ZHEN;  Zhao Qi
Adobe PDF | Favorite |  | Submit date：2024/08/28
Protein nanoparticles as drug delivery systems for cancer theranostics Journal article
Hua, Yue, Qin, Zibo, Gao, Lin, Zhou, Mei, Xue, Yonger, Li, Yue, Xie, Jinbing. Protein nanoparticles as drug delivery systems for cancer theranostics[J]. Journal of Controlled Release, 2024, 371, 429-444.
Authors:  Hua, Yue;  Qin, Zibo;  Gao, Lin;  Zhou, Mei;  Xue, Yonger; et al.
Favorite | TC[WOS]:5 TC[Scopus]:6  IF:10.5/10.6 | Submit date：2024/09/03
cancer imaging  cancer therapy  drug delivery  Protein nanoparticles  
Protein nanoparticles as drug delivery systems for cancer theranostics Review article
2024
Authors:  Hua Yue;  Qing Zibo;  Gao Lin;  Zhou Mei;  Xue Yonger; et al.
Adobe PDF | Favorite | TC[WOS]:5 TC[Scopus]:6  IF:10.5/10.6 | Submit date：2024/08/13
Protein Nanoparticles  Cancer Imaging  Cancer Therapy  Drug Delivery  
Biomimetic nano-chelate diethyldithiocarbamate Cu/Fe for enhanced metalloimmunity and ferroptosis activation in glioma therapy Journal article
Wang, Rui, Song, Wenqin, Zhu, Jie, Shao, Xinyue, Yang, Chenxiao, Xiong, Wei, Wang, Bing, Zhao, Pengfei, Chen, Meiwan, Huang, Yongzhuo. Biomimetic nano-chelate diethyldithiocarbamate Cu/Fe for enhanced metalloimmunity and ferroptosis activation in glioma therapy[J]. Journal of Controlled Release, 2024, 368, 84-96.
Authors:  Wang, Rui;  Song, Wenqin;  Zhu, Jie;  Shao, Xinyue;  Yang, Chenxiao; et al.
Favorite | TC[WOS]:8 TC[Scopus]:8  IF:10.5/10.6 | Submit date：2024/05/02
Anti-glioma  Diethyldithiocarbamate Cu/fe  Immunogenic Cell Death  Ferroptosis  Metalloimmunology  Albumin  Lactoferrin  Brain-targeted Delivery